Rhumbline Advisers decreased its position in shares of Envista Holdings Co. (NYSE:NVST – Get Rating) by 0.9% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 423,369 shares of the company's stock after selling 3,942 shares during the period. Rhumbline Advisers owned approximately 0.26% of Envista worth $20,622,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also bought and sold shares of the company. EFG Asset Management North America Corp. bought a new position in Envista during the first quarter valued at $2,257,000. Principal Financial Group Inc. increased its position in Envista by 140.5% during the first quarter. Principal Financial Group Inc. now owns 1,318,947 shares of the company's stock valued at $64,247,000 after acquiring an additional 770,581 shares during the last quarter. Eversept Partners LP increased its position in Envista by 4.7% during the fourth quarter. Eversept Partners LP now owns 849,298 shares of the company's stock valued at $38,269,000 after acquiring an additional 38,417 shares during the last quarter. Champlain Investment Partners LLC increased its position in Envista by 0.5% during the fourth quarter. Champlain Investment Partners LLC now owns 813,855 shares of the company's stock valued at $36,672,000 after acquiring an additional 3,810 shares during the last quarter. Finally, Buckley Wealth Management LLC bought a new position in Envista during the first quarter valued at $324,000.
Get Envista alerts:Envista Stock Performance
NVST stock opened at $36.60 on Thursday. Envista Holdings Co. has a one year low of $34.75 and a one year high of $52.03. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.88 and a current ratio of 1.11. The firm has a market cap of $5.98 billion, a price-to-earnings ratio of 21.79, a PEG ratio of 1.42 and a beta of 1.54. The firm has a 50-day simple moving average of $38.88 and a two-hundred day simple moving average of $42.19.
Wall Street Analyst Weigh In
A number of brokerages have recently issued reports on NVST. Piper Sandler raised shares of Envista from a "neutral" rating to an "overweight" rating and boosted their target price for the company from $40.00 to $46.00 in a research note on Monday, August 29th. Robert W. Baird lowered shares of Envista from an "outperform" rating to a "neutral" rating and lowered their price objective for the stock from $54.00 to $46.00 in a research note on Tuesday, June 14th. TheStreet lowered shares of Envista from a "b" rating to a "c+" rating in a research note on Friday, June 17th. The Goldman Sachs Group lowered their price objective on shares of Envista from $58.00 to $45.00 and set a "buy" rating for the company in a research note on Thursday, July 21st. Finally, Stifel Nicolaus lowered their price objective on shares of Envista from $55.00 to $50.00 in a research note on Friday, June 17th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, Envista currently has a consensus rating of "Moderate Buy" and a consensus price target of $46.86.Envista Company Profile
(Get Rating)
Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic brands; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Insignia, AOA, and Spark brands.
Featured Stories
- Get a free copy of the StockNews.com research report on Envista (NVST)
- 3 High Margin Chipmakers Bound to Recover
- 3 Solar Stocks That Will Benefit From the Biden Tariff Holiday
- REV Group Has A Deep Moat In The World Of EVs
- Is G-III Apparel Group, Ltd. A Value Trap?
- Bank Of America Sees Upside In These 2 European Alcohol Stocks
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.